ÂÜÀòÂÒÂ×

Brenda Dooley is an accomplished Chief Executive Officer at AXIS Healthcare Consulting Ltd since January 2012, specializing in Pricing, Reimbursement, Strategic Market Access, and Health Technology Assessments in the UK and Ireland. In addition, Brenda serves as an Investment Committee Member and Risk and Audit Committee Member at the National University of Ireland, Galway since June 2017. Previously, Brenda held the position of Director of Market Access & Health Service Relations at Pfizer from June 2003 to July 2011, focusing on Pricing, Reimbursement, and Market Access for the Irish market while establishing corporate relations with government and non-government entities. Brenda's earlier roles include Market Access Head at Pharmacia & Upjohn, Sales Manager, and Marketing Manager at Abbott Laboratories. Brenda's educational background includes an MSc (Hons) in Health Economics from the University of Galway, a Diploma (Hons) in Financial Management from ACCA, a BA (Hons) in Business Studies from the University of Wales Trinity Saint David, and a Diploma in Marketing from the Marketing Institute of Ireland.